Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related TEVA
Drug Price Hike Concerns Spill Over Into Other Pharma Stocks
Have You Heard About This Generic EpiPen Maker?
A Comprehensive Look at Dividend Growth Stock Valuations Sector by Sector: Part — (GuruFocus)
Related JASO
The Market In 5 Minutes: Retailers Keep The Earnings Party Going
JA Solar Investors Applaud Q2 Results, Outlook

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Aug 2016BTIG ResearchMaintainsBuy
Jul 2016HSBCUpgradesHoldBuy
Jul 2016OppenheimerMaintainsOutperform

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (INDB + JASO)

View Comments and Join the Discussion!